Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca's head and neck cancer treatment Imfinzi falls flat in Phase III trials

pharmafileDecember 10, 2018

Tag: AstraZeneca , HNSCC , PD-L1

PharmaSources Customer Service